共 35 条
- [21] One-Year Respiratory Outcomes of Preterm Infants Enrolled in the Nitric Oxide (to Prevent) Chronic Lung Disease Trial JOURNAL OF PEDIATRICS, 2008, 153 (04): : 525 - 529
- [30] Safety of Palivizumab in Preterm Infants 29 to 32 Weeks' Gestational Age Without Chronic Lung Disease to Prevent Serious Respiratory Syncytial Virus Infection European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 414 - 417